No profile data available.
PTC Therapeutics, Inc. (PTCT) is a healthcare company in the brain and nerve treatment drugs industry, based in Warren, United States, with about 991 full-time employees.
It reported revenue of $1.73 billion for fiscal year 2025, up 114.5% from fiscal year 2024, and net income of $682.64 million. United States was its largest region in fiscal year 2025, with 86% of revenue. Its market capitalization was $5.40 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to children and adults living with rare disorders in the United States and internationally.
PTC Therapeutics reported $1.73 billion in revenue for fiscal year 2025, up 114.5% from $806.78 million in fiscal year 2024.
United States: 86% of revenue by region in fiscal year 2025, followed by Outside of the United States (14%).
$5.40 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (brain and nerve treatment drugs) include Axsome Therapeutics, Inc. (AXSM), Praxis Precision Medicines, Inc. (PRAX), Alkermes plc (ALKS), Scholar Rock Holding Corporation (SRRK).